Bayesian neural network with pretrained protein embedding enhances prediction accuracy of drug-protein interaction
Not on the map. Why?
Abstract (arXiv)
The characterization of drug-protein interactions is crucial in the high-throughput screening for drug discovery. The deep learning-based approaches have attracted attention because they can predict drug-protein interactions without trial-and-error by humans. However, because data labeling requires significant resources, the available protein data size is relatively small, which consequently decreases model performance. Here we propose two methods to construct a deep learning framework that exhibits superior performance with a small labeled dataset. At first, we use transfer learning in encoding protein sequences with a pretrained model, which trains general sequence representations in an unsupervised manner. Second, we use a Bayesian neural network to make a robust model by estimating the data uncertainty. As a result, our model performs better than the previous baselines for predicting drug-protein interactions. We also show that the quantified uncertainty from the Bayesian inference is related to the confidence and can be used for screening DPI data points.
Key facts. Cited by 7 papers in the map (data through 7 Oct 2026). First posted on arXiv 15 Dec 2020.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2021: 1; 2022: 0; 2023: 0; 2024: 2; 2025: 2; 2026: 2.
7 papers.
- 2021A Survey of Uncertainty in Deep Neural Networkscited by 675
- 2024Enhancing Uncertainty Quantification in Drug Discovery with Censored Regression Labelscited by 5
- 2024Achieving Well-Informed Decision-Making in Drug Discovery: A Comprehensive Calibration Study using Neural Network-Based Structure-Activity Modelscited by 2
- 2025Drug-Target Interaction/Affinity Prediction: Deep Learning Models and Advances Reviewcited by 2
- 2025Temporal Distribution Shift in Real-World Pharmaceutical Data: Implications for Uncertainty Quantification in QSAR Modelscited by 1
- 2026Co-Diffusion: An Affinity-Aware Two-Stage Latent Diffusion Framework for Generalizable Drug-Target Affinity Predictioncited by 0
- 2026LaPro-DTA: Latent Dual-View Drug Representations and Salient Protein Feature Extraction for Generalizable Drug--Target Affinity Predictioncited by 0
- 2026LaPro-DTA: Latent Dual-View Drug Representations and Salient Protein Feature Extraction for Generalizable Drug--Target Affinity Prediction16 Mar 2026
- 2026Co-Diffusion: An Affinity-Aware Two-Stage Latent Diffusion Framework for Generalizable Drug-Target Affinity Prediction11 Mar 2026
- 2025Drug-Target Interaction/Affinity Prediction: Deep Learning Models and Advances Review21 Feb 2025
- 2025Temporal Distribution Shift in Real-World Pharmaceutical Data: Implications for Uncertainty Quantification in QSAR Models6 Feb 2025
- 2024Enhancing Uncertainty Quantification in Drug Discovery with Censored Regression Labels6 Sep 2024
- 2024Achieving Well-Informed Decision-Making in Drug Discovery: A Comprehensive Calibration Study using Neural Network-Based Structure-Activity Models19 Jul 2024
- 2021A Survey of Uncertainty in Deep Neural Networks7 Jul 2021